Reumatoloxía

2012

1. A meta-analysis of mortality in rheumatic diseases

   Reumatologia Clinica, Vol. 8, Núm. 6, pp. 334-341

2. A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.

   Arthritis and rheumatism, Vol. 64, Núm. 4, pp. 970-981

3. Adipokines as biomarkers of rheumatic diseases

   Drugs of the Future, Vol. 37, Núm. 8, pp. 591-597

4. Adiponectin and Leptin Induce VCAM-1 Expression in Human and Murine Chondrocytes

   PLoS ONE, Vol. 7, Núm. 12

5. Analysis of the Interferon Gamma (rs2430561, +874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis

   PLoS ONE, Vol. 7, Núm. 10

6. Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis

   Arthritis Research and Therapy, Vol. 14, Núm. 3

7. Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy

   Mediators of Inflammation, Vol. 2012

8. Análisis comparativo de células madre mesenquimales procedentes de pacientes artrósicos y sanos en diferenciación condrogénica

   Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 88-88

9. Association of a BMP5 microsatellite with knee osteoarthritis: Case-control study

   Arthritis Research and Therapy, Vol. 14, Núm. 6

10. Association of anti-citrullinated vimentin and anti-citrullinated α-enolase antibodies with subsets of rheumatoid arthritis

    Arthritis and Rheumatism, Vol. 64, Núm. 10, pp. 3102-3110

11. Association of ferritin autoantibodies with giant cell arteritis/ polymyalgia rheumatica

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 6, pp. 943-947

12. Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis

    Scandinavian Journal of Rheumatology, Vol. 41, Núm. 5, pp. 350-353

13. Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients

    DNA and Cell Biology, Vol. 31, Núm. 8, pp. 1412-1417

14. Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population

    Clinical and Experimental Rheumatology, Vol. 30, Núm. SUPPL. 70

15. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 4, pp. 575-581

16. Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: A case-control study

    Arthritis Research and Therapy, Vol. 14, Núm. 2

17. Biologic monotherapy as initial treatment in patients with early rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 51, Núm. SUPPL.5

18. Búsqueda de biomarcadores séricos de artrosis mediante depleción secuencias combinada con DIGE

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 111-111

19. Calcium supplementation and kidney stone risk in osteoporosis: A systematic literature review

    Clinical and Experimental Rheumatology, Vol. 30, Núm. 6, pp. 954-961

20. Características de los pacientes con espondiloartritis seguidos en unidades de reumatología en España. Estudio emAR II

    Reumatologia Clinica, Vol. 8, Núm. 3, pp. 107-113